Characteristics of carbohydrate metabolism indicators in diabetic patients with acute coronary syndrome

Halushko O. A.,
D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine

Boliuk M. V.,
P. L. Shupyk National University of Health Care of Ukraine, Kyiv, Ukraine

Key words: diabetes mellitus, myocardial infarction, acute coronary syndrome, pain, hyperglycemia, CAD, glycemic gap


Studies show that all patients with uncontrolled glucose levels are at increased risk of complications during hospitalization. It has been proven that there is a relationship between the level of hyperglycemia and in-hospital mortality in patients admitted with myocardial infarction (MI). Aim. To study the features of carbohydrate metabolism indicators in diabetic patients with acute coronary syndrome. Materials and methods. The study included 48 patients (38 men and 10 women) aged 45-83 years, urgently hospitalized for acute coronary syndrome (ACS). Blood samples were collected from all patients to determine the level of glycated hemoglobin (HbA1c). Blood glucose (BG) was determined at the time of hospitalization and after revascularization. Glycemic level and glycemic interval were determined at the time of hospitalization and after revascularization using a calculation method. The relationship between the levels of glycemia, glycated hemoglobin and glycemic gap and the influence on the course of acute coronary syndrome in diabetic patients, namely the development of complications (recurrent MI, cardiac arrest, pulmonary aedema, life- threatening arrhythmias, the need for mechanical ventilation) was determined. Results. The following complications of ACS were recorded: paroxysmal tachycardia with narrow QRS complexes (4.17%); paroxysm of atrial fibrillation (4.17%); pulmonary aedema (8.34%); mechanical ventilation (4.17%). We did not observe cardiac arrest or repeated MI. The average value of glycemia at the time of hospitalization was 8.19±3.41 mmol/l. Glycemia over 10.0 mmol/l was found in 20.83% of patients, and BG over 7.0 mmol/l was observed in 47.92% of patients. After revascularization, the average value of glycemia was 6.42±1.62 mmol/l. HbA1c >6.4% was observed in 29.17% of patients, and greater than 7.0% – in 25.0% of patients. Hyperglycemia >7.0 mmol/L at the time of hospitalization was significantly (p=0.049) more common in patients with type 2 diabetes. Glycated hemoglobin and estimated average glycemia by ADAG were higher in patients with type 2 diabetes (p=0.038). There was a trend towards the predominance of increased glycated hemoglobin (>7.0 mmol/l) in patients with ACS complications (p=0.094) and differences in glycemic gap values in patients with complications (p=0.052). No correlation was found between the glycemic gap and the occurrence of ACS complications (р=0.275). Conclusions. Hyperglycemia is often observed in patients with ACS; patients with coronary artery desease often have poorly controlled diabetes; in diabetic patients with ACS complications there is a tendency to predominate in the frequency of an increased level of glycated hemoglobin (>7.0 mmol/l) (p=0.094) and differences in the values of the glycemic gap (p=0.052); glycemic gap can probably be a predictor of the development of life-threatening complications of ACS in patients with DM, and further clinical studies involving a larger number of patients of different ages and different ethnic groups are needed to reliably confirm this hypothesis.


1. Johnstone M, Veves A, за ред. Diabetes and Cardiovascular Disease [Інтернет]. Cham: Springer International Publishing; 2023 [цит. за 01, June 2024]. (Contemporary Cardiology). Доступний у: 13177-6

2. Halushko O., Bolyuk M. Acute Coronary Syndrome in Patients with Diabetes mellitus: Features of the Course and Manifestations of Pain Syndrome. Family Medicine, 2022, (1-2), 1318. https://

3. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004 Sep 11-17;364(9438):937-52.

4. Lee CD, Folsom AR, Pankow JS, Brancati FL; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004 Feb 24;109(7):855-60. doi: 10.1161/01.CIR.0000116389.61864.DE

5. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000 Mar 4;355(9206):773-8. doi: 10.1016/ S0140-6736(99)08415-9.

6. Marfella R, Sasso FC, Cacciapuoti F, Portoghese M, Rizzo MR, Siniscalchi M, et al. Tight glycemic control may increase regenerative potential of myocardium during acute infarction. J Clin Endocrinol Metab. 2012 Mar;97(3):933-42. doi: 10.1210/ jc.2011-2037.

7. Marfella R, Di Filippo C, Portoghese M, Ferraraccio F, Rizzo MR, Siniscalchi M, et al. Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol. 2009 Apr 21;53(16):1425-36. doi: 10.1016/j. jacc.2009.01.041.

8. Halushko O., Boliuk M. The risks and difficulties of diagnosing myocardial infarction in diabetic patients (review and own experience). EMERGENCY MEDICINE, 2020; 16(2), 3741.

9. Boliuk M., Halushko O. The features of the pain syndrome in diabetic patients with myocardial infarction.

10. EMERGENCY MEDICINE, 2021; 17(2), 7278. https://doi. org/10.22141/2224-0586.17.2.2021.230651

11. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.

12. Unified clinical protocol of emergency, primary, secondary (specialized) and tertiary (highly specialized) medical care and medical rehabilitation “acute coronary syndrome with ST segment elevation” [Internet]. Ministry of Health of Ukraine; 2014. Available at: uploads/2019/11/2014_455-ykpmd_gks.pdf

13. Multidisciplinary working group. Diabetes. Evidence- based clinical practice. Ministry of Health of Ukraine. State enterprise “State Expert Center of the Ministry of Health of Ukraine”. Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine. Diabetes Obesity Metabolic syndrome. 2023; XII(1): 8-93.

14. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008 Aug;31(8):1473-8. doi: 10.2337/dc08-0545.

15. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, et al. Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study. Diabetes. 2010 Jul;59(7):1585-90. doi: 10.2337/db09-1774.

16. Klonoff DC. ADAG study group data links A1C levels with empirically measured blood glucose values — new treatment guidelines will now be needed. J Diabetes Sci Technol. 2014 May;8(3):439-43. doi: 10.1177/1932296814529638.

17. Donagaon S, Dharmalingam M. Association between Glycemic Gap and Adverse Outcomes in Critically Ill Patients with Diabetes. Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):208-211. doi: 10.4103/ijem.IJEM_580_17.

18. Liao WI, Wang JC, Chang WC, Hsu CW, Chu CM, Tsai SH. Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With Diabetes. Medicine (Baltimore). 2015 Sep;94(36):e1525. doi: 10.1097/ MD.0000000000001525.

19. Xia W, Li C, Kuang M, Wu Y, Xu L, Hu H. Predictive value of glycemic gap and stress glycemia ratio among critically ill patients with acute kidney injury: a retrospective analysis of the MIMIC- III database. BMC Nephrol. 2023 Aug 1;24(1):227. doi: 10.1186/ s12882-023-03278-z.

20. Intensive versus Conventional Glucose Control in Critically Ill Patients | New England Journal of Medicine [Інтернет]. [цит. за 05, Червень 2024]. Доступний у: full/10.1056/NEJMoa0810625

21. Liao WI, Wang JC, Chang WC, Hsu CW, Chu CM, Tsai SH. Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With Diabetes. Medicine (Baltimore). 2015 Sep;94(36):e1525. doi: 10.1097/MD.0000000000001525.

22. Hsing SC, Lin C, Chen JT, Chen YH, Fang WH. Glycemic Gap as a Useful Surrogate Marker for Glucose Variability and Progression of Diabetic Retinopathy. J Pers Med. 2021 Aug 16;11(8):799. doi: 10.3390/jpm11080799.

23. Wang M, Su W, Cao N, Chen H, Li H. Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023 Mar 21;22(1):63. doi: 10.1186/s12933-023- 01790-y.

24. Ghanem YM, Ayad MW, Kareem AA, Guirguis MO, Alkafafy AM, Badrah MH. Glycemic gap and the outcome of diabetic patients presenting with acute coronary syndrome. The Egyptian Journal of Internal Medicine. 24, January, 2022;34(1):10. 



How to Cite

Halushko O. A., Boliuk M. V. (2024). Characteristics of carbohydrate metabolism indicators in diabetic patients with acute coronary syndrome. Diabetes Obesity Metabolic Syndrome. 13(3), 26-33